| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/27/1997 | WO1997011171A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 03/27/1997 | WO1997011170A1 Antisense oligonucleotide chemotherapy for benign hyperplasia or cancer of the prostate |
| 03/27/1997 | WO1997011169A2 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed |
| 03/27/1997 | WO1997011163A1 Pskh-1 ribozymes and uses in disease treatment |
| 03/27/1997 | WO1997011096A1 Anti-inflammatory agent |
| 03/27/1997 | WO1997011095A1 Uses of bone morphogenetic proteins |
| 03/27/1997 | WO1997011092A1 Cyclosporin phosphate derivatives and medicinal composition |
| 03/27/1997 | WO1997011091A1 Novel peptide compounds and medicinal compositions thereof |
| 03/27/1997 | WO1997011090A1 Inhibition of tumor growth |
| 03/27/1997 | WO1997011089A1 Treatment of patients with idiopathic dilated cardiomyopathy |
| 03/27/1997 | WO1997010854A1 (radio) labelled biotin derivatives |
| 03/27/1997 | WO1997010852A2 Xsns-type bi-functional sulphide-containing sulphonamide chelating agents for radioactive isotopes |
| 03/27/1997 | WO1997010851A2 Nucleic acid delivery vehicle |
| 03/27/1997 | WO1997010850A1 Transcytosis vehicles and enhancers for drug delivery |
| 03/27/1997 | WO1997010849A1 Copolymeric micelle drug composition and method for the preparation thereof |
| 03/27/1997 | WO1997010847A1 Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells |
| 03/27/1997 | WO1997010846A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | WO1997010842A1 COMBINATION OF β-INTERFERON FOR THE TREATMENT OF PROSTATE CANCER |
| 03/27/1997 | WO1997010841A1 Antiangiogenic properties of endothelial-monocyte activating polypeptide ii |
| 03/27/1997 | WO1997010840A1 Anti-inflammatory antisense drug |
| 03/27/1997 | WO1997010839A1 Compositions and methods for inhibiting the binding of pecam |
| 03/27/1997 | WO1997010838A1 Use of one or more peptides in a cosmetic composition or for the preparation of a medicament |
| 03/27/1997 | WO1997010837A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 03/27/1997 | WO1997010836A1 Peptides and peptidomimetics inhibiting the oncogenic action of p21 ras |
| 03/27/1997 | WO1997010831A1 Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
| 03/27/1997 | WO1997010828A1 Therapy for tissue membrane insufficiency |
| 03/27/1997 | WO1997010821A1 Enhancement of erectile function with renin-angiotensin system inhibitors |
| 03/27/1997 | WO1997010819A1 Treating niddm with rxr agonists |
| 03/27/1997 | WO1997010813A1 Ppar gamma antagonists for treating obesity |
| 03/27/1997 | WO1997010806A1 Aerosol compositions |
| 03/27/1997 | WO1997010711A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
| 03/27/1997 | WO1997005875A3 A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus |
| 03/27/1997 | WO1997005258A3 Recombinant 60kda vegetable panallergen (co-factor-independent phosphoglycerate mutase; e.c. 5.4.2.1.) |
| 03/27/1997 | WO1997005253A3 Transketolase-related protein |
| 03/27/1997 | WO1997001636A3 Recombinant mistletoe lectin |
| 03/27/1997 | WO1997000088A3 Rotavirus enterotoxin nsp4 and methods of using same |
| 03/27/1997 | WO1996040082A3 Apparatus and method for delivering a biologically active compound into a biological environment |
| 03/27/1997 | WO1996034596A3 Use of emu oil for stimulating skin and hair growth |
| 03/27/1997 | WO1996029974A3 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 03/27/1997 | DE19536818A1 Use of beta-interferon to treat patients with prostate cancer |
| 03/27/1997 | DE19536785A1 Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ S¶2¶NY für radioaktive Isotope Bifunctional sulfide-containing sulfonamide-type chelating agent S¶2¶NY for radioactive isotopes |
| 03/27/1997 | DE19536781A1 Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ XSNS für radioaktive Isotope Bifunctional sulfide-containing sulfonamide-type chelating agent XSNS for radioactive isotopes |
| 03/27/1997 | DE19535701A1 New (opt. protected) phosphorylated insulin cpds. |
| 03/27/1997 | DE19535321A1 Neues Adhäsin aus Helicobacter pylori Create an adhesin of Helicobacter pylori |
| 03/27/1997 | CA2658039A1 Human growth hormone variants |
| 03/27/1997 | CA2239976A1 Antisense oligonucleotide chemotherapy for benign hyperplasia or cancer of the prostate |
| 03/27/1997 | CA2232834A1 Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells |
| 03/27/1997 | CA2232750A1 Peptides and peptidomimetics inhibiting the oncogenic action of p21 ras |
| 03/27/1997 | CA2232730A1 New adhesin from helicobacter pylori |
| 03/27/1997 | CA2232724A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 03/27/1997 | CA2232601A1 Recombinant proteins having multiple disulfide bonds and thiol-substituted conjugates thereof |
| 03/27/1997 | CA2232411A1 (radio) labelled biotin derivatives |
| 03/27/1997 | CA2232391A1 Bifunctional sulfide-containing sulfonamide-chelating agents such as xsns for radioactive isotypes |
| 03/27/1997 | CA2232390A1 Antisense oligonucleotide chemotherapy for benign hyperplasia or cancer of the prostate |
| 03/27/1997 | CA2232360A1 Enhancement of erectile function with renin-angiotensin system inhibitors |
| 03/27/1997 | CA2232301A1 Pskh-1 ribozymes and uses in disease treatment |
| 03/27/1997 | CA2232299A1 Uses of bone morphogenetic proteins |
| 03/27/1997 | CA2232193A1 Dna encoding medicinal proteins |
| 03/27/1997 | CA2231251A1 Histone deacetylase as target for antiprotozoal agents |
| 03/27/1997 | CA2231172A1 Nucleic acid delivery vehicle |
| 03/27/1997 | CA2230479A1 Transcytosis vehicles and enhancers for drug delivery |
| 03/27/1997 | CA2230127A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | CA2230119A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
| 03/27/1997 | CA2230116A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | CA2229845A1 Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
| 03/27/1997 | CA2222035A1 Streptavidin mutants |
| 03/26/1997 | EP0764722A2 DNA encoding primate leptins as medicinal proteins |
| 03/26/1997 | EP0764721A1 ATP-sensitive potassium-channel proteins and genes for the same |
| 03/26/1997 | EP0764444A1 Use of at least one peptide in a cosmetic composition or for the preparation of a medicine |
| 03/26/1997 | EP0764442A1 Use of specific sulphur containing aminos acid derivatives against pathogenic viral or prion particles |
| 03/26/1997 | EP0764441A1 Cosmetic or dermopharmaceutical patch containing at least one active agent, particularly an unstable one in an oxidative medium, and at least one hydroabsorbent in an anhydrous polymeric matrix |
| 03/26/1997 | EP0764273A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
| 03/26/1997 | EP0764208A1 Bmp-9 compositions |
| 03/26/1997 | EP0764207A1 Modified cells and methods for inhibiting hyperacute rejection of xenogeneic transplants |
| 03/26/1997 | EP0764205A1 Chondroitin lyase enzymes |
| 03/26/1997 | EP0764204A1 HUMAN OXALYL-CoA DECARBOXYLASE |
| 03/26/1997 | EP0764172A1 Synthetic peptide analogs of lung surfactant protein sp-c |
| 03/26/1997 | EP0764171A1 Ligands for induction of antigen specific apoptosis in t cells |
| 03/26/1997 | EP0764170A1 Branched synthetic peptide conjugate |
| 03/26/1997 | EP0764169A2 Drug salts |
| 03/26/1997 | EP0764167A1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme |
| 03/26/1997 | EP0764152A1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors |
| 03/26/1997 | EP0764030A1 Use of autoantibodies for tumor therapy and prophylaxis |
| 03/26/1997 | EP0764028A2 Method of treating retained pulmonary secretions |
| 03/26/1997 | EP0764026A1 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
| 03/26/1997 | EP0764021A1 Uterine fibroid treatment |
| 03/26/1997 | EP0764017A1 Methods and compositions for disrupting the epithelial barrier function |
| 03/26/1997 | EP0759292B1 Use of alpha type melanocytes stimulating hormone derivatives to stimulate the hairgrowth |
| 03/26/1997 | EP0642531B1 Monomer and dimer peptides, utilization as cytoprotector agents and preparation method |
| 03/26/1997 | EP0559751B1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
| 03/26/1997 | EP0546087B1 Protein structure of the plant toxin gelonin |
| 03/26/1997 | EP0535067B1 Endonucleases |
| 03/26/1997 | EP0482080B1 Small cyclic platelet aggregation inhibitors |
| 03/26/1997 | CN1146241A Method of determining suppressor cell component of immune status of individual and means for carrying out the same |
| 03/26/1997 | CN1146208A Peptides as therapeutic agents for treatment of auto-immune diseases |
| 03/26/1997 | CN1146207A Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/26/1997 | CN1146157A Fibrin-specific antibody for use as an antithrombrotic agent |
| 03/26/1997 | CN1146156A Means for treating auto-immune diseases and method of treatment |
| 03/26/1997 | CN1146155A Method for implanting encapsulated cells in a host |
| 03/26/1997 | CN1146136A Targeted cytolysis of HIV-infected cells by Chimeric CD4 receptor bearing cells |